How Do Regulatory Agencies Manage Faster Approval?
Regulatory agencies like the FDA and EMA have implemented several pathways to facilitate faster approval of cancer treatments. These include programs such as Accelerated Approval, Priority Review, and Breakthrough Therapy Designation. These pathways aim to expedite the review process for drugs that show promise in early trials, allowing them to reach patients more quickly while still undergoing necessary evaluations.
